Clinical Trials List
2022-08-25 - 2026-11-03
Phase III
Recruiting4
ICD-10B44.1
Other pulmonary aspergillosis
ICD-10B44.2
Tonsillar aspergillosis
ICD-10B44.7
Disseminated aspergillosis
ICD-10B44.89
Other forms of aspergillosis
ICD-10B44.9
Aspergillosis, unspecified
ICD-10B48.4
Penicillosis
ICD-9117.3
Aspergillosis
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chau-Chyun Sheu Division of Thoracic Medicine
- Yi-Chang Liu Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- Tun-Chieh Chen Division of Infectious Disease
- Ming-Ju Tsai Division of Thoracic Medicine
- Chun-Yuan Lee Division of Infectious Disease
- Chung-Hao Huang Division of Infectious Disease
- Hung-Ling Huang Division of Thoracic Medicine
- 鄭孟軒 Division of Thoracic Medicine
- Shang-Yi Lin Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳泓恩 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSIN-AN HOU Division of General Internal Medicine
- 陳抱宇 Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- Chien-Chin Lin Division of Others -
- BANG-BIN CHEN Division of Radiology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tzu-Tao Chen Division of Thoracic Medicine
- JING-QUAN ZHENG Division of Thoracic Medicine
- Ching-Shan Luo Division of Thoracic Medicine
- Kuan-Yuan Chen Division of Thoracic Medicine
- Wen-Te Liu Division of Thoracic Medicine
- YUN-KAI YEH Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
123 participants
